Methods for lowering blood sugar with a gliflozin sodium-glucose cotransporter 2 inhibitor pharmaceutical composition
A pharmaceutical composition and a technique for gilliflozin sodium are applied in the field of lowering blood sugar by using the gliflozin sodium (gliflozin sodium)-glucose co-transporter 2 inhibitor pharmaceutical composition, and can solve problems such as unachieved results and the like
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
example 1
[0375] Example 1: A computer system configured to qualify an individual for over-the-counter delivery of a dapagliflozin pharmaceutical composition for treating diabetes (eg, by lowering blood sugar). The computer system includes instructions for conducting a survey of an individual. Using a survey to obtain one or more of the following outcomes: whether the individual is pregnant, breastfeeding, or planning to become pregnant; the individual's type 1 diabetes status; the individual's ketoacidosis status; the individual's renal disease status; the individual's age; the individual's blood sugar level ; whether the individual has liver problems; whether the individual has ever had urinary problems; the individual's surgical status; the individual's dietary status; whether the individual has ever had pancreatic problems; the individual's alcohol consumption status; whether the individual is using diabetes medications; Bladder Cancer.
[0376] The computer system runs the finding...
example 2
[0385] Example 2: A computer system configured to qualify an individual for over-the-counter delivery of a canagliflozin pharmaceutical composition for the treatment of diabetes (eg, by lowering blood sugar). The computer system includes instructions for conducting a survey of an individual. Using a survey to obtain one or more of the following outcomes: whether the individual is pregnant, breastfeeding, or planning to become pregnant; the individual's type 1 diabetes status; the individual's ketoacidosis status; the individual's renal disease status; the individual's age; the individual's blood sugar level ; whether the individual has liver problems; whether the individual has ever had urinary problems; the individual's surgical status; the individual's dietary status; whether the individual has ever had pancreatic problems; the individual's alcohol consumption status; whether the individual is using diabetes medications; The subject's history of resection; the subject's hist...
example 3
[0395] Example 3: A computer system configured to qualify an individual for over-the-counter delivery of an epagliflozin pharmaceutical composition for the treatment of diabetes (eg, by lowering blood sugar). The computer system includes instructions for conducting a survey of an individual. Using a survey to obtain one or more of the following outcomes: whether the individual is pregnant, breastfeeding, or planning to become pregnant; the individual's type 1 diabetes status; the individual's ketoacidosis status; the individual's renal disease status; the individual's age; the individual's blood sugar level ; whether the individual has liver problems; whether the individual has ever had urinary problems; the individual's surgical status; the individual's dietary status; whether the individual has ever had pancreatic problems; the individual's alcohol consumption status; whether the individual is using diabetes medications; The subject's history of leg neuropathy; and the subje...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More